Heather Raymon
Corporate Officer/Principal presso Artiva Biotherapeutics, Inc.
Profilo
Heather Raymon is currently the SVP-Research & Early Development at Artiva Biotherapeutics, Inc. Prior to this, she worked as the Executive Director-Early Development Program at Bristol Myers Squibb Co. and as the Senior Director & Head-Pharmacology at Celgene Corp.
Dr. Raymon received her undergraduate degree from the State University of New York at Albany and her doctorate degree from the University of California, Irvine.
Posizioni attive di Heather Raymon
| Società | Posizione | Inizio |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/10/2020 |
Precedenti posizioni note di Heather Raymon
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formazione di Heather Raymon
| State University of New York at Albany | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Heather Raymon
